Farampator

DB15012InvestigationalSmall molecule

Farampator is under investigation in clinical trial NCT00113022 (Org 24448 to Treat Major Depression).

Chemical structure of Farampator
Formula / weight
C12H13N3O2 · 231.255 g/mol (avg)
Code names
ORG 24448

Resolves to

Compound
UNII7X6P5N8K2LCAS211735-76-1ChEMBLCHEMBL1276138
Structure
InChIKeyXFVRBYKKGGDPAJ-UHFFFAOYSA-NSMILESO=C(N1CCCCC1)C1=CC2=NON=C2C=C1
Targets
P42261GRIA1

What you can answer from here — as of April 23, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Farampator, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In